Stock Markets June 3, 2026 08:06 PM

Quantinuum Prices 28 Million-Share IPO at $60, Sets Nasdaq Debut for June 4

Quantum computing company grants underwriters an option for 4.2 million additional shares; offering subject to customary closing conditions

By Leila Farooq

Quantinuum Inc. has priced an initial public offering of 28 million shares of Class A common stock at $60.00 per share and granted underwriters a 30-day option to buy up to 4.2 million additional shares at the IPO price. The company intends to list on the Nasdaq Global Market under the ticker QNT beginning June 4, 2026, with the expected closing of the offering on June 5, 2026, pending customary closing conditions. The Securities and Exchange Commission declared the registration statement effective on June 3, 2026. The underwriting syndicate is led by J.P. Morgan and Morgan Stanley, with a broad group of additional managers and co-managers. Quantinuum operates from Broomfield, Colorado, and maintains facilities across several countries.

Quantinuum Prices 28 Million-Share IPO at $60, Sets Nasdaq Debut for June 4

Key Points

  • Quantinuum priced its IPO at $60.00 per share for 28 million Class A shares, with a 30-day overallotment option for up to 4.2 million additional shares.
  • Shares are expected to begin trading on the Nasdaq Global Market on June 4, 2026 under the ticker QNT, with the offering expected to close on June 5, 2026, subject to customary closing conditions.
  • A syndicate led by J.P. Morgan and Morgan Stanley, along with multiple other book-running managers and co-managers, is handling the offering; the SEC declared the registration statement effective on June 3, 2026.

Quantinuum Inc. has set the terms for its initial public offering, announcing the sale of 28 million shares of Class A common stock at a price of $60.00 per share. The company also granted the underwriters a 30-day option to purchase up to 4.2 million additional shares at the IPO price to cover over-allotments.

The stock is expected to begin trading on the Nasdaq Global Market on June 4, 2026 under the ticker symbol "QNT". The offering is expected to close on June 5, 2026, subject to customary closing conditions.

Leading the underwriting effort as joint lead active book-running managers are J.P. Morgan and Morgan Stanley. Jefferies and Evercore ISI are also named as active book-running managers. A broader syndicate of joint book-running managers includes BofA Securities, UBS Investment Bank, Cantor, Mizuho, Needham & Company, Societe Generale and TD Cowen. Craig-Hallum and Rosenblatt are serving as co-managers for the transaction.

The Securities and Exchange Commission declared the registration statement for the offering effective on June 3, 2026. The company noted that the offering will be made available only through a prospectus.

Quantinuum describes itself as a quantum computing company providing a full-stack platform to support deployment of quantum computing capabilities. The company is headquartered in Broomfield, Colorado, and lists additional facilities in the United States, United Kingdom, Germany, Japan, Qatar and Singapore.


Offering details

  • Shares offered: 28,000,000 Class A common shares.
  • IPO price: $60.00 per share.
  • Overallotment option: Up to 4,200,000 additional shares, exercisable within 30 days at the IPO price.
  • Expected Nasdaq listing date: June 4, 2026, ticker symbol QNT.
  • Expected closing date: June 5, 2026, subject to customary closing conditions.

Underwriting syndicate

  • Joint lead active book-runners: J.P. Morgan and Morgan Stanley.
  • Active book-running managers: Jefferies and Evercore ISI.
  • Additional joint book-running managers: BofA Securities, UBS Investment Bank, Cantor, Mizuho, Needham & Company, Societe Generale and TD Cowen.
  • Co-managers: Craig-Hallum and Rosenblatt.

This release provides the principal terms of the offering and a description of Quantinuum's operations and geographic footprint. No additional projections, forecasts or forward-looking statements are included here; the company has stated the offering will be made available through a prospectus.

Risks

  • The offering's completion is subject to customary closing conditions, meaning the planned closing on June 5, 2026 is not guaranteed - this could affect capital markets and investor allocations.
  • Underwriters hold a 30-day option to purchase additional shares, which could increase the number of shares sold and affect dilution and market supply in the technology and quantum computing sector.
  • The offering will be made available only through a prospectus, limiting distribution to the terms and disclosures contained in that document; availability constraints may affect investor access in the broader capital markets.

More from Stock Markets

Toronto market ends at fresh record as healthcare, financials and materials lead gains Jun 4, 2026 After-Hours Movers: Lululemon Dips on Guidance as Software and Data Names Show Mixed Reactions Jun 4, 2026 Lululemon Lowers Fiscal 2026 Revenue and EPS Guidance as U.S. Demand Softens Jun 4, 2026 Anthropic Places Engineers Inside NSA to Support Mythos AI for Offensive Cyber Tasks Jun 4, 2026 Trump Directs $700M Toward Coal Industry, Lifting Peabody Shares Jun 4, 2026